- Home
- DPRO vs ANTX Comparison
DPRO vs ANTX Comparison
Compare DPRO & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- ANTX
- Stock Information
- Founded
- DPRO 1998
- ANTX 2017
- Country
- DPRO Canada
- ANTX United States
- Employees
- DPRO N/A
- ANTX N/A
- Industry
- DPRO Aerospace
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- DPRO Industrials
- ANTX Health Care
- Exchange
- DPRO Nasdaq
- ANTX Nasdaq
- Market Cap
- DPRO 38.9M
- ANTX 33.2M
- IPO Year
- DPRO N/A
- ANTX 2022
- Fundamental
- Price
- DPRO $4.98
- ANTX $1.08
- Analyst Decision
- DPRO Strong Buy
- ANTX Buy
- Analyst Count
- DPRO 2
- ANTX 2
- Target Price
- DPRO $6.50
- ANTX $2.00
- AVG Volume (30 Days)
- DPRO 7.7M
- ANTX 78.6K
- Earning Date
- DPRO 08-19-2025
- ANTX 08-19-2025
- Dividend Yield
- DPRO N/A
- ANTX N/A
- EPS Growth
- DPRO N/A
- ANTX N/A
- EPS
- DPRO N/A
- ANTX N/A
- Revenue
- DPRO $4,716,450.00
- ANTX N/A
- Revenue This Year
- DPRO $66.19
- ANTX N/A
- Revenue Next Year
- DPRO $101.07
- ANTX N/A
- P/E Ratio
- DPRO N/A
- ANTX N/A
- Revenue Growth
- DPRO 7.90
- ANTX N/A
- 52 Week Low
- DPRO $1.55
- ANTX $0.87
- 52 Week High
- DPRO $7.31
- ANTX $2.70
- Technical
- Relative Strength Index (RSI)
- DPRO 52.84
- ANTX 49.34
- Support Level
- DPRO $4.76
- ANTX $1.03
- Resistance Level
- DPRO $5.43
- ANTX $1.09
- Average True Range (ATR)
- DPRO 0.63
- ANTX 0.03
- MACD
- DPRO -0.15
- ANTX 0.00
- Stochastic Oscillator
- DPRO 21.18
- ANTX 39.68
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.